The patent landscape of bioprinting, despite a recent whirlwind of notoriety, has been slowly developing for years. In a recent Pharma Focus Asia article, Robert W. Esmond discusses three patents covering various phases of bioprinting, the patent infringement exemption for experimental uses, and the prospects for future patentability.

To read the full article, visit Pharma Focus Asia’s website.

Related Industries

Related Services